Publications and communications of Christelle Sanchez

Raman, R., Bahri, M. A., Degueldre, C., Caetano da Silva, C., Sanchez, C., Ostertag, A., Collet, C., Cohen-Solal, M., Plenevaux, A., Henrotin, Y., & Muller, M. (14 January 2024). A Zebrafish Mutant in the Extracellular Matrix Protein Gene efemp1 as a Model for Spinal Osteoarthritis. Animals, 14 (1), 74. doi:10.3390/ani14010074

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F. M. F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R. J., Muller, M., Elewaut, D., Hammond, C. L., Sanchez, C., & Henrotin, Y. (20 September 2023). Osteomodulin downregulation is associated with osteoarthritis development. Bone Research, 11 (1), 49. doi:10.1038/s41413-023-00286-5

Sanchez, C., Zappia, J., Lambert, C., FOGUENNE, J., Dierckxsens, Y., Dubuc, J.-E., Delcour, J.-P., Gothot, A., & Henrotin, Y. (11 August 2022). Curcuma longa and Boswellia serrata Extracts Modulate Different and Complementary Pathways on Human Chondrocytes In Vitro: Deciphering of a Transcriptomic Study. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.931914

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (20 December 2021). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Cartilage, 13 (Issue 2_suppl), 862S-871. doi:10.1177/1947603519870855

Sanchez, C., Hemmer, K., Krömmelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (11 May 2021). Reduction of Matrix Metallopeptidase 13 and Promotion of Chondrogenesis by Zeel T in Primary Human Osteoarthritic Chondrocytes. Frontiers in Pharmacology, 12, 1-12. doi:10.3389/fphar.2021.635034

Lambert, C., Zappia, J., Sanchez, C., Florin, A., Dubuc, J.-E., & Henrotin, Y. (2021). The Damage-Associated Molecular Patterns (DAMPs) as Potential Targets to Treat Osteoarthritis: Perspectives From a Review of the Literature. Frontiers in Medicine, 7, 607186. doi:10.3389/fmed.2020.607186

Florin, A., Lambert, C., Sanchez, C., Zappia, J., Durieux, N., Tieppo, A. M., Mobasheri, A., & Henrotin, Y. (2020). The secretome of skeletal muscle cells: A systematic review. Osteoarthritis and Cartilage Open. doi:10.1016/j.ocarto.2019.100019

Zappia, J., Joiret, M., Sanchez, C., Lambert, C., Geris, L., Muller, M., & Henrotin, Y. (2020). From translation to protein degradation as mechanisms for regulating biological functions: A review on the SLRP family in skeletal tissues. Biomolecules, 10, 80. doi:10.3390/biom10010080

de Visser, H. M., Sanchez, C., Mastbergen, S. C., Lafeber, F. P. J. G., Henrotin, Y., & Weinans, H. (2019). Fib3-3 as a Biomarker for Osteoarthritis in a Rat Model with Metabolic Dysregulation. Cartilage, 10 (3), 329-334. doi:10.1177/1947603518754629

Elango, J., Sanchez, C., de Val, J. E. M. S., Henrotin, Y., Wang, S., Motaung, K. S. C. M., Guo, R., Wang, C., Robinson, J., Regenstein, J. M., Bao, B., & Wu, W. (2018). Cross-talk between primary osteocytes and bone marrow macrophages for osteoclastogenesis upon collagen treatment. Scientific Reports, 8 (1), 5318. doi:10.1038/s41598-018-23532-x

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (2018). Comparison of secretome from osteoblasts derived from sclerotic versus non-sclerotic subchondral bone in OA: A pilot study. PLoS ONE, 13 (3), 0194591. doi:10.1371/journal.pone.0194591

Sanchez, C., Bay-Jensen, A.-C., Pap, T., Dvir-Ginzberg, M., Quasnichka, H., Barrett-Jolley, R., Mobasheri, A., & Henrotin, Y. (August 2017). Chondrocyte secretome: a source of novel insights and exploratory biomarkers of osteoarthritis. Osteoarthritis and Cartilage, 25, 1199-1209. doi:10.1016/j.joca.2017.02.797

Comblain, F., Dubuc, J.-E., Lambert, C., Sanchez, C., Lesponne, I., Serisier, S., & Henrotin, Y. (2016). Identification of Targets of a New Nutritional Mixture for Osteoarthritis Management Composed by Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract. PLoS ONE. doi:10.1371/journal.pone.0156902

Henrotin, Y., Sanchez, C., Bay-Jensen, A. C., & Mobasheri, A. (June 2016). Osteoarthritis biomarkers derived from cartilage extracellular matrix: Current status and future perspectives. Annals of Physical and Rehabilitation Medicine, 59 (3), 145-148. doi:10.1016/j.rehab.2016.03.004

Runhaar, J.* , Sanchez, C.* , Taralla, S., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (April 2016). Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women. Osteoarthritis and Cartilage, 24 (4), 672-678. doi:10.1016/j.joca.2015.10.013

Oprenyeszk, F., Sanchez, C., Dubuc, J.-E., Maquet, V., Henrist, C., Compère, P., & Henrotin, Y. (28 May 2015). Chitosan enriched three-dimensional matrix reduces inflammatory and catabolic mediators production by human chondrocytes. PLoS ONE, 10 (5). doi:10.1371/journal.pone.0128362

Comblain, F., Sanchez, C., Lesponne, I., Balligand, M., Serisier, S., & Henrotin, Y. (2015). Curcuminoids Extract, Hydrolyzed Collagen and Green Tea Extract Synergically Inhibit Inflammatory and Catabolic Mediator's Synthesis by Normal Bovine and Osteoarthritic Human Chondrocytes in Monolayer. PLoS ONE. doi:10.1371/journal.pone.0121654

Horcajada, M.-N.* , Sanchez, C.* , Membrez Scalfo, Drion, P., Comblain, F., Taralla, S., Donneau, A.-F., Offord, E. A., & Henrotin, Y. (2015). Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig. Osteoarthritis and Cartilage, 23 (1), 94-102. doi:10.1016/j.joca.2014.08.016

Sanchez, C., Horcajada, M.-N., Membrez Scalfo, F., Ameye, L., Offord, E., & Henrotin, Y. (2015). Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes. PLoS ONE, 10 (8), 0136118. doi:10.1371/journal.pone.0136118

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (30 May 2023). Urolithin A and B accelerate myocyte fusion into myotubes. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1926-1927. doi:10.1136/annrheumdis-2023-eular.3536

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Kague, E., Lories, R., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (30 May 2023). Osteomodulin down-regulation is associated with osteoarthritis development. Annals of the Rheumatic Diseases, 82 (Suppl 1), 1194-1195. doi:10.1136/annrheumdis-2023-eular.1006

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (March 2023). Deciphering Urolithins A And B Activities On Muscle: Transcriptomic Modulation On Human Primary Myotubes. Osteoarthritis and Cartilage, 31, 303. doi:10.1016/j.joca.2023.01.316

Zappia, J., Tong, Q., Van der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Grisart, J., Muller, M., Elewaut, D., Hammond, C., Sanchez, C., & Henrotin, Y. (March 2023). Osteomodulin Is Involved In Bone And Cartilage Homeostasis And Osteoarthritis Development. Osteoarthritis and Cartilage, 31, 323-S324. doi:10.1016/j.joca.2023.01.350

Henrotin, Y., Lambert, C., Florin, A., Zappia, J., Centonze, P., & Sanchez, C. (December 2022). Évaluation de l’activité des urolithines A et B sur le muscle : modulation transcriptomique sur les myotubes primaires humains. Revue du Rhumatisme, 89, 49-A50. doi:10.1016/j.rhum.2022.10.061

Zappia, J., Van Der Cruyssen, R., Cornelis, F., Lambert, C., Pinto Coelho, T., Lories, R., Elewaut, D., Sanchez, C., & Henrotin, Y. (December 2022). L’ostéomoduline joue un rôle majeur dans l’homéostasie de l’os et du cartilage. Revue du Rhumatisme, 89, 176. doi:10.1016/j.rhum.2022.10.261

Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (April 2021). Development of a primary skeletal muscle cell culture model from human muscle biopsies. Osteoarthritis and Cartilage, 29 (Suppl), 108.

Zappia, J., Van der Cruyssen, R., Sanchez, C., Lausberg, C., Lambert, C., Florin, A., Elewaut, D., & Henrotin, Y. (April 2021). Osteomodulin Impacts Positively The Bone Remodeling Process In Osteoarthritis. Bone Reports, 14 (Suppl 1), 2352-1872. doi:10.1016/j.bonr.2021.100904

Florin, A., Lambert, C., Sanchez, C., Zappia, J., & Henrotin, Y. (December 2020). Mise au point d’un modèle de culture original de cellules musculaires squelettiques à partir de biopsies musculaires humaines. Revue du Rhumatisme, Volume 87 (Supplément 1). doi:10.1016/j.rhum.2020.10.433

Sanchez, C., Hemmer, K., Kroemmelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (June 2020). A multicomponent medication promotes chondrogenesis and reduces MMP-13 in primary articular chondrocytes from knee osteoarthritis patients in vitro. Annals of the Rheumatic Diseases, 79 (Suppl 1), 1336.

Sanchez, C., Zappia, J., Dierckxsens, Y., Delcour, J.-P., & Henrotin, Y. (June 2020). Boswellia serrata extract and curcumin increase GDF15 production by human primary osteoarthritis chondrocytes: a new mechanism of action. Annals of the Rheumatic Diseases, 79 (Suppl 1), 1336-1337.

Sanchez, C., Hemmer, K., Krommelbein, N., Seilheimer, B., Dubuc, J.-E., Antoine, C., & Henrotin, Y. (April 2020). A multicomponent medication promotes chondrogenesis and reduces MMP-13 in primary articular chondrocytes from knee osteoarthritis patients in vitro. Osteoarthritis and Cartilage, 28 (Suppl 1), 106-107. doi:10.1016/j.joca.2020.02.171

Sanchez, C., Zappia, J., Dierckxsens, Y., Delcour, J.-P., & Henrotin, Y. (April 2020). Boswellia serrata extract and curcumin increase GDF15 production by human primary osteoarthritis chondrocytes: a new mechanism of action. Osteoarthritis and Cartilage, 28 (Suppl 1), 120.

Sanchez, C., Lambert, C., Dubuc, J.-E., Bertrand, J., Pap, T., & Henrotin, Y. (June 2019). Syndecan-4 is Increased in Osteoarthritic Knee, but not Hip or Shoulder, Articular Hypertrophic Chondrocytes. Annals of the Rheumatic Diseases, 78 (Suppl 2), 1508.

Sanchez, C., Lambert, C., Dubuc, J., Bertrand, J., Pap, T., & Henrotin, Y. (November 2018). Le syndécan-4 est un marqueur de l’hypertrophie des chondrocytes du genou arthrosique. Revue du Rhumatisme, 85S, 327.

Sanchez, C., Mazzucchelli, G., Comblain, F., Lambert, C., De Pauw, E., & Henrotin, Y. (June 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Annals of the Rheumatic Diseases, 77 (supplement 2), 894.

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (April 2018). Proteomic analysis of osteoblasts secretome provides new insights in mechanisms underlying osteoarthritis subchondral bone sclerosis. Osteoarthritis and Cartilage, 26 (supplement 1), 89. doi:10.1016/j.joca.2018.02.192

Sanchez, C., Mazzucchelli, G., Lambert, C., Comblain, F., De Pauw, E., & Henrotin, Y. (December 2017). L’analyse protéomique du sécrétome des ostéoblastes fournis de nouvelles indications sur les mécanismes de la sclérose sous-chondrale dans l’arthrose. Revue du Rhumatisme, 84 (S1), 295.

Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (April 2017). Study of the evolution of the osteoarthritis pathology and the mechanical properties of cartilage in a spontaneous osteoarthritis model in the Dunkin-Hartley guinea pigs. Osteoarthritis and Cartilage, 25, 314-s315.

Legrand, C., Centonze, P., Comblain, F., Lambert, C., Sanchez, C., & Henrotin, Y. (November 2016). Étude de l’évolution de la pathologie arthrosique et des propriétés mécaniques du cartilage sur un modèle d’arthrose spontanée chez le cobaye Dunkin-Hartley. Revue du Rhumatisme, 83S, 209-A210. doi:10.1016/S1169-8330(16)30512-9

Legrand, C., Lambert, C., Comblain, F., Sanchez, C., & Henrotin, Y. (April 2016). Review of soluble biomarkers of osteoarthritis: lessons from animal model. Osteoarthritis and Cartilage, 24 (suppl 1), 88.

Sanchez, C., Lambert, C., Comblain, F., Legrand, C., & Henrotin, Y. (April 2016). Osteoarthritic sclerotic subchondral osteoblasts secreted elevated concentration of fibulin-3 fragments in vitro. Osteoarthritis and Cartilage, 24 (suppl 1), 83.

Runhaar, J., Sanchez, C., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (April 2015). Baseline Fibulin3 concentrations are associated with incidence of clinical knee OA after 30 months in overweight and obese women. Osteoarthritis and Cartilage, 23 (S2), 83. doi:10.1016/j.joca.2015.02.782

Runhaar, Sanchez, C., Taralla, S., Henrotin, Y., & Bierma-Zeinstra, S. M. A. (2015). Baseline Fibulin3 Concentrations Are Associated with Incidence of Clinical Knee OA after 30 Months in Overweight and Obese Women. Arthritis and Rheumatism, 67 (Suppl10).

Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Guillou, B., & Reginster, J.-Y. (2001). Long-term Effects of Avocado/Soybean Unsaponifiable on Human Chondrocytes Metabolism. Tissue Engineering, 7 (5), 648.

Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Diacerein by its Metabolite Rhein, Down-Regulates Stromelysins and Nitric Oxide Productions and Up-Regulates Aggrecan Production by Human Chondrocytes in Alginate Beads. Tissue Engineering, 7 (5), 648.

Sanchez, C., Deberg, M., Reginster, J.-Y., & Henrotin, Y. (2001). Long-term Effects of Nonsteroidal Antiinflammatory Drugs on Human Chondrocytes in Alginate Beads. Annals of the Rheumatic Diseases, 60 (suppl1), 284.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (30 January 2019). OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (27 September 2017). Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof.

Henrotin, Y., Sanchez, C., De Pauw, E., & Mazzucchelli, G. (25 September 2017). Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (18 November 2014). Intra-articularly supplementation method for treating joint diseases and injuries.

Henrotin, Y., Kesteloot, F., & Sanchez, C. (11 November 2014). Cell cultivation in chitosan alginate hydrogel beads.

Henrotin, Y., Sanchez, C., Oprenyeszk, F., & Drion, P. (02 January 2013). An intra-articular supplement for use in treating joint diseases and injuries.